alterations possibly reflecting tinnitus are scarce. Various spectrum of electrophysiological cochleoneural activity (ASECA), degrees of increase in spontaneous activity of auditory neua measure of spontaneous auditory nerve activity, was monitored rons after salicylate administration were reported at the level in guinea pigs over weeks of salicylate administration. Auditory nerve compound action potential (CAP) was also recorded to mon-of the auditory nerve (Evans and Borerwe 1982; Evans et itor acoustic sensitivity. In the first days of treatment, ASECA al. 1981; Kumagai 1992; Stypulkowski 1990) , the inferior decreased acutely during hours after salicylate administration; after colliculus (Chen and Jastreboff 1995; Jastreboff and Sasaki several days this decrease could be reduced. Over weeks of treat-1986; Manabe et al. 1997) , and the auditory cortex (Ochi ment the level of ASECA increased progressively. No change in and Eggermont 1996). An ensemble measure of auditory CAP threshold was observed. The ASECA decrease induced by a nerve spontaneous firings can be obtained from the average contralateral broadband noise remained unchanged. At the end of spectrum of recordings in silent conditions from a gross treatment, acoustic tuning of ASECA showed a partially decreased electrode on the nerve or on the cochlear round window sensitivity. After cessation of treatment the ASECA level returned (Cazals and Huang 1996; Dolan et al. 1990; Schreiner and progressively to initial values. In control animals delivery of an ipsilateral acoustic noise could reproduce the ASECA increase Snyder 1987). This average spectrum measure was found observed in long-term salicylate-treated animals. This white noise to be altered after a single high dose of salicylate (Martin was of moderate sound pressure level and it elevated slightly CAP et al. 1993; Schreiner and Snyder 1987) . Similar measures thresholds at high frequencies. These data provide evidence for performed in humans at the occasion of eighth nerve surgery salicylate-induced ASECA alterations without changes in CAP indicated that in several patients affected with tinnitus the thresholds, in accord with clinical reports of tinnitus being the average spectrum of activity of the auditory nerve was alfirst subjective sign of salicylate ototoxicity. The similarities in tered (Feldmeier and Lenarz 1996; Martin et al. 1995) . Most occurrence, development, reversibility, frequency content, and physiological observations from animal experiments were acoustic level support the idea that ASECA changes, which indicates alterations of spontaneous eighth nerve activity and reflects obtained after a single high dose of salicylate and in acute the presence of salicylate-induced high-pitch tinnitus.
conditions; this obviously differs from humans for whom high doses of salicylate were repeatedly administered over days. In animal studies with repetitive daily doses of salicy-
I N T R O D U C T I O N
late (Boettcher and Salvi 1991; Crifo 1975; Gold and Wilpizeski 1966) very small hearing losses, measured electroThere is little evidence of the physiological bases of tinniphysiologically or behaviorally, were reported. There is tus either from clinical observations or from animal experievidence that tinnitus in animals progressively develops over ments. The most common experimental approach to produce days of salicylate treatment (Jastreboff and Sasaki 1994). tinnitus is administration of high doses of salicylate. It has
The use of chronically implanted electrodes and the testing long been known from clinical studies that daily high doses of awake animals allows long-term monitoring and avoids of aspirin can, after several days, induce tinnitus and a modalterations of the average spectrum of cochlear activity inerate hearing loss, both being reversible at cessation of treatduced by acute conditions (Cazals and Huang 1996) . This ment (McCabe and Dey 1965; Myers and Bernstein 1965) . study was undertaken with chronically implanted animals to Tinnitus often appears as the first subjective symptom and monitor both the average spectrum of cochlear activity and sounds like a high-pitch noise (Day et al. 1989 ; Mongan et the hearing sensitivity of animals undergoing days of treatal. 1973) . Physiological experiments established that salicyment with salicylate. An objective of this study was to deterlate affects the cochlea (Boettcher and Salvi 1991; Silmine whether alterations of spontaneous cochleoneural acverstein et al. 1967; Stypulkowski 1990) , two major sites of action being the vascular supply (Cazals et al. 1988 ; tivity would somehow parallel the progression of tinnitus the electrophysiological testing session started each morning before over days of salicylate treatment as described in humans and the first injection of salicylate. Electrophysiological recordings observed from animal behavior.
consisted either in a short session of recordings before the first injection to assess progression of long-term treatment or could last several hours to monitor the acute effects of salicylate injection.
M E T H O D S
Lidocaine is a drug known to be able to temporarily alleviate Adult pigmented guinea pigs with body weights Ç250 -300 g tinnitus in humans. In these experiments, lidocaine (Sigma) was at the beginning of the experiments were used in this study. They dissolved in 50% ethanol at a dose of 1 g/10 ml and injected were chronically implanted with a platinum-ball electrode on the intramuscularly. In pilot experiments on control animals several round window of the cochlea and two brass screws at the frontal doses were tried; the dose of 100 mg/kg sometimes resulted in cortex, which served as reference and ground electrodes. A detailed abnormal behavioral signs after Ç30 min. In salicylate-treated anidescription of the implantation and other recording techniques can mals lidocaine was used at a dose of 40 mg/kg. be found in a previous publication (Cazals and Huang 1996) . All animals were given at least 1 wk rest after the operation, and all R E S U L T S subsequent experimental measures were taken from awake chronically implanted animals.
As previously described, ASECA recordings at the round During recording sessions of average spectrum of electrophysio-window in silent conditions and from awake guinea pigs logical cochleoneural activity (ASECA) and compound action po-exhibited a similar pattern from all animals with a first peak tential (CAP) the animals were kept in a double-wall soundproof of maximal energy at the lowest frequencies up to Ç100 Hz cabin (Industrial Acoustic or Amplifon). To maintain constant followed by a valley Ç500 Hz and a broad peak centeredÇ1 acoustic conditions and to keep the animal quiet for electrophysiokHz. Examples of ASECA from three animals are given in logical recordings, the animal was placed in a restraining box with Fig. 1 , where it can be seen that the spectral profile at the its head gently maintained with a neck and a nose ring to which all lowest frequencies could vary somewhat from animal to anianimals became quickly accustomed. For ASECA measurements electrophysiological signals from the round window were amplified mal, whereas other parts of the average spectrum were quite 1,000 times filtered between 1 and 10 kHz and digitized through similar between animals. The changes in ASECA during salicylate treatment conin a microcomputer. A rejection level of 30 mV peak at the electrode was used, and several 10-s recordings were obtained. Then fast Fourier transforms were performed on 300 partitions of 2,048 points, which served for spectral averaging. Thus a frequency resolution of 10.7 Hz was obtained. For each spectral point a magnitude value was computed and expressed in decibels with the formula 20 log (M/R) in which M is the computed rms magnitude and R is a reference taken as 1 nV rms/ Hz. To examine possible changes of ASECA at frequencies ú10 kHz, some recordings were made at a sampling rate of 44,100 Hz. The CAP of the auditory nerve was used to assess hearing thresholds. An earphone was placed at 1 cm in front of the ear to be tested to deliver acoustic stimuli. The acoustical calibrations were performed by placing a 1 / 2 -in. condenser microphone in place of the animal's ear, and levels were measured and expressed in decibels of SPL. To evoke CAPs, tone pips of various frequencies were used having an envelope of 2-ms linear rise and fall times and no plateau. Tone pips frequencies were chosen from 0.5 to 16 kHz in octave steps and in third octave steps for the highest 20 and 25 kHz. Averaging of CAP was performed by usingÇ200 sweeps. Threshold detection was visually determined after averaging and the reproducibility thus obtained was around 3 dB. During salicylate treatment CAP thresholds were measured two to three times per week. Ipsilateral stimulation with continuous broadband noise or pure tones was used to examine their effects on ASECA or CAP. Examining effects of contralateral noise is a way of assessment of the medial olivocochlear efferent action; contralateral broadband noise was delivered through a tube glued to the external auditory canal allowing interaural attenuation of Ç50 dB as described previously (Cazals and Huang 1996) .
For salicylate treatment, salicylic acid sodium salt (Sigma-Aldrich) was dissolved in saline at a dose of 200 mg/ml. Salicylate Doses of 200 mg/kg were delivered twice a day at Ç0900 and guinea pigs treated for 3 wk. Each panel of curves corresponds to 1 animal 1800. In a first experiment a treatment of 21 days was designed, whose number is given in the bottom left corner. Top panel, wideband and one group of three treated animals and one group of four spectrum (up to the highest frequencies recorded); bottom panels, spectral control animals were constituted. In a second experiment a shorter span of actual change; middle curve, before begining of treatment; bottom 14-day treatment was administered to four animals while two con-curve, after 1 wk of treatment and 2 h after the first daily salicylate injection; trol animals were monitored in parallel. The control animals re-top curve, after 3 wk of treatment and before first daily injection. Horizontal dotted lines are given as visual guides to assess amplitude changes.
ceived an equivalent injection of saline. During all experiments, J1007-7 / 9k2d$$oc45 09-30-98 08:49:32 neupa LP-Neurophys sisted of an acute decrease during hours after the administration of salicylate and, in contrast, in a moderate and progressive increase over days of treatment. In Fig. 1 are presented for each of three animals a decreased ASECA as obtained 2 h after administration of salicylate and an increased ASECA as observed after 3 wk of treatment. It can be seen that the changes occur mostly and consistently at frequencies between 100 and 2 kHz and that the maximum of variation is observed at the 1-kHz peak. The amplitude of this peak was thus used as a measure of variations in all subsequent experiments. All animals presented at initial measure, before starting treatments, differences of a few decibels in the absolute value of the ASECA-1-kHz peak; consequently the data were expressed for each animal as a change from its own initial value. The time course of ASECA-1-kHz changes over 9 h after an injection of salicylate shows that at the first day of treatment a strong decrease was observed, whereas after 2 and 3 wk of treatment this decrease could be considerably attenuated; examples from three animals are given in Fig.  2 . In all cases no change in CAP threshold was detected during these 9-h sessions.
In contrast in these same animals the level of ASECA-1 kHz increased progressively over days of salicylate treatment. As can be seen in Fig. 3 this increase amounted to Ç1-1.5 dB after 1 wk, Ç2 dB after 2 wk, and for two animals reached Ç3 dB at the end of the 3 wk of treatment. In the control saline-treated animals no such change was daily salicylate injection for 3 guinea pigs. ᭺, at first day; q, at end of 2 wk; ᭢, at end of 3 wk.
observed; the values for the various animals fluctuated ran-J1007-7 / 9k2d$$oc45 09-30-98 08:49:32 neupa LP-Neurophys domly withinÇ0.5 dB, as can be seen in Fig. 3 . After 3 wk of treatment no change in CAP threshold was detected for all but one animal. For the animal that showed the highest increase in ASECA at the end of 3 wk of treatment a very small CAP threshold elevation of õ10 dB was detected at the two highest frequencies, 25 and 32 kHz. At cessation of treatment the ASECA-1 kHz returned progressively to initial values. As can be seen in Fig. 3 , the animal that presented the least increase recovered in Ç1 wk, whereas the animal with the largest increase took Ç14 wk to recover. To further document the reversibility of the ASECA increase a second group of animals was treated for 2 wk. Results presented in Fig. 4 show that ASECA increased quite similarly to the previous experiment but did not reach so high levels as the treament was limited to 2 wk, and for all animals a return to normal was observed Ç2 wk after cessation of salicylate treatment.
ASECA is known to increase in response to an ipsilateral broadband acoustic stimulus for normal cochleas. At the end of the treatment period, the control animals of the first group were presented with an ipsilateral white noise at various sound pressure levels. The acoustic level of the noise was increased progressively until the ASECA-1-kHz level was increased byÇ2 dB, as seen in the salicylate-treated animals. This external acoustic noise produced an increase in the ASECA profile affecting the frequencies between 100 and 2 kHz similarly to changes induced by long-term salicylate treatment. This is illustrated in the middle panel of band noise 3 mo after the end of treatment. For comparison the effects of an external noise was also measured in animals at the end of the 3-wk treatment. The increase of ASECA-1 kHz with external acoustic noise was similar to that observed in control animals, as illustrated in the top graph of Fig. 5 . A level of Ç55 dB SPL was found necessary to further elevate the ASECA-1 kHz by Ç2 dB. The effects of this noise on CAP threshold elevation showed that it induced a moderate threshold elevation of Ç15 dB at 8 kHz in control animals; in treated animals a somewhat greater threshold elevation was seen at 8 kHz, with an additional significant elevation at 4 kHz. All the above-mentioned results are presented in Fig. 5 .
It was well established that in normal cochleas presentation of ipsilateral pure tones produces decreases of the ASECA-1 kHz with a maximal sensitivity at 16-20 Hz. At the end of the 3 wk of salicylate treatment, the effects of various pure tones were tested on the salicylate treated and Fig. 6 . A decrease of 3 dB was taken as criterion to draw tuning curves of ASECA-1-kHz reduction. From control animals these tuning curves exhibit a best sensitivity Ç16-20 kHz; in salicylate-treated animals they appear broader, with elevated thresholds and with a best sensitivity shifted toward 8 kHz. For comparison with the previously mentioned results of ipsilateral broadband noise, the control animals were presented with a broadband ipsilateral noise increasing ASECA-1 kHz by Ç2 dB, and then, in the presence of this continuous noise, effects of pure tones were measured. The 03 dB tuning curve obtained in these conditions was quite similar to that obtained from the same normal cochleas without a continuous noise as shown in Fig. 6 . The efferent cochlear innervation of the medial olivococh- was previously shown by effects of contralateral broadband band noise level in 1 guinea pig before treatment (᭺) and after 1 (q), noise. These effects were examined in animals treated with 2 (᭢), and 3 () wk of salicylate treatment. salicylate for 3 wk; no change was observed over the 3 wk of treament compared with effects measured before treat-sented some general muscular contraction with an extension ment. An example of data obtained from one animal is given of their back. No change in ASECA or CAP threshold was in Fig. 7 . observed at any dose. In salicylate-treated animals at the end Lidocaine has been shown to be rather effective in reduc-of the 3-wk treatment a dose of 40 mg/kg was injected ing or suppressing tinnitus in human. Lidocaine was injected intramuscularly. No change in ASECA or CAP was detected intramuscularly in control animals at various doses, and over the following 4 h. ASECA and CAP were monitored for 6 h after injection. When a dose of 100 mg/kg was used some abnormal behavioral signs were observed after Ç30 min; the animals pre-D I S C U S S I O N The results of this study revealed two main findings. The long-term salicylate treatment induced alterations of ASECA without modification of CAP. The characteristics of ASECA changes appeared remarkably similar to the characteristics of salicylate-induced tinnitus in humans and animals. These two aspects are first discussed, and then possible underlying physiological mechanisms are discussed.
ASECA more sensitive than CAP thresholds to incipient salicylate ototoxicity
Previous studies in the guinea pig showed that ipsilateral pure tones, at levels warranting no acoustic cross-talk to the contralateral ear, only induce decreases of the ASECA-1-kHz peak (Dolan et al. 1990 ), whereas ipsilateral noises produce increases of the ASECA-1-kHz peak at least when their bandwidth exceeds 1.5 kHz (Cazals and Huang 1996) . In view of properties of ASECA responses to various sounds compared with known response properties of nerve fibers, there is compelling evidence that the ASECA-1-kHz peak in the guinea pig originates from a restricted tonotopic area corresponding to the high frequencies of 16-20 kHz and that it should correspond to a synchronized spontaneous firing of fibers (Cazals and Huang 1996) . Consequently, ASECA-1-kHz decrease as seen in acute effects of salicylate during hours postinjection should indicate decrease of synchronized cates that ASECA was a more sensitive measure of incipient J1007-7 / 9k2d$$oc45 09-30-98 08:49:32 neupa LP-Neurophys cochlear pathophysiology. The absence of CAP threshold together with a decrease of the broader peak at 1 kHz (Martin et al. 1993; Schreiner and Snyder 1987) . In agreement with elevation observed in this study is in line with previous reports that showed somewhat variable but very small hear-these observations this study on guinea pigs showed a decrease of the 1-kHz peak during hours after an injection of ing losses for long-term salicylate treatment. By using clickevoked brain stem potentials and 2 wk of salicylate treatment salicylate; it also showed that this decrease can occur without elevation in CAP thresholds. Recordings of ASECA from in the cat and the guinea pig, a statistically nonsignificant loss of°4 dB was observed (Gold and Wilpizeski 1966) . the auditory nerve in humans during surgery provided evidence of ASECA alterations in patients suffering from tinniBy using behavioral audiometry in the guinea pig an average of 10 dB hearing loss appeared between the beginning of tus similar to those earlier reported from animal experiments after an injection of salicylate (Martin et al. 1995) . Clinical treatment and after 3 wk (Crifo 1975) ; in the chinchilla after 2 wk of salicylate treatment an average loss of õ8 dB reports indicate that during long-term salicylate treatment in humans tinnitus occurs after several days, becomes louder was reported (Boettcher and Salvi 1991) .
The decrease of ASECA seen over several hours after as treatment is continued, and sounds as a high-pitch noise (Day et al. 1989; McCabe and Dey 1965 ; Mongan et al. salicylate injection shows a minimum after Ç2 h and then a progressive recovery in Ç8 h; this time course is similar 1973). Behavioral experiments with rats also give evidence of tinnitus occurring after several days of treatment, increasto that often reported for CAP threshold changes in previous reports (Cazals et al. 1988; Didier et al. 1993 ; Gold and ing in loudness with duration of treatment, and having a high pitch (Jastreboff and Sasaki 1994). The ASECA increase Wilpizeski 1966; Myers and Bernstein 1965) . In this study no change in CAP threshold was observed during hours after observed in this study also occurs after several days of salicylate treatment, increases progressively as treatment is continan injection of salicylate, certainly because the dose of each injection (1/2 daily injections) was only 200 mg/kg, less ued, and can be mimicked in control animals by presentation of an ipsilateral white noise, which affects the high frequenthan used in the previously cited studies. The similar time course probably reflects a similarity in underlying physiolog-cies as shown by induced CAP threshold elevations. The loudness of salicylate-induced tinnitus over long-term salicyical processes, and ASECA measures there also appear more sensitive than CAP thresholds to incipient pathophysiology. late treatment was matched by humans to pure tone acoustic levels ranging from Ç20 to 60 dB SPL (Day et al. 1989 ); The reduction of acute postinjection ASECA decrease after 2 and 3 wk of treatment was stronger in animals that showed in rats behavioral measures of tinnitus level was found equivalent to a high-frequency pure tone ranging from 20 to 60 the higher long-term increase of ASECA. Also dependent on the amount of ASECA increase observed at the end of dB SPL (Jastreboff and Sasaki 1994). In these experiments mimicking the salicylate-induced ASECA increase required the treatment was the duration of return of ASECA to initial control values after cessation of treatment. The reversibility white noise levels of Ç55 dB SPL. The occurrence of ASECA alterations without changes in CAP thresholds apis in correspondence with the reported simultaneous reversibility of tinnitus and hearing loss always observed in hu-pears in correspondence with the occurrence of tinnitus as a first subjective symptom of salicylate ototoxicity reported mans when salicylate treatment is discontinued. Recovery durations from human data were rarely followed and were by humans (Day et al. 1989; McCabe and Dey 1965; Mongan et al. 1973 ). These converging similarities in occurmeasured only for hearing loss; recovery periods range from a few days to 2 wk and show large interindividual variability rence, development, reversibility, frequency content, and acoustic level support the idea that ASECA changes reflect with no apparent relation to the duration of treatment, serum salicylate level, or amount of hearing loss (Long and Tubis the presence of salicylate-induced tinnitus.
An ipsilateral broadband noise produced an ASECA-1kHz 1988; Myers and Bernstein 1965) .
increase similar to that induced by salicylate elevated CAP thresholds, whereas no CAP threshold elevation was induced Similarities between ASECA changes and tinnitus induced by salicylate treatment. The threshold elevations induced by by salicylate the ipsilateral broadband noise in salicylate-treated animals were greater than those in control animals. This is to be Tinnitus is the perception of a sound in the absence of a corresponding similar sound in the subject's external envi-expected in the hypothesis of salicylate inducing an internal noise increasing ASECA to which presentation of an external ronment; most often it is clearly perceived in silent conditions and disappears in even moderately noisy conditions. noise would add and produce a larger threshold elevation.
In control animals the ASECA-1-kHz peak decrease inNeurophysiologically tinnitus must be expressed by some abnormal spontaneous neural activity in auditory structures. duced by ipsilateral pure tones shows a relatively broad tuning with a best sensitivity of Ç16-20 kHz. In salicylate-ASECA recorded in silent conditions is known to reflect spontaneous activity of the auditory nerve (Cazals and Hu-treated animals the decrease induced by pure tones was found reduced for tones above 8 kHz. The ASECA-1-kHz ang 1996; Dolan et al. 1990; Schreiner and Snyder 1987; Zheng et al. 1996) . Depending on animal species, electrode peak can be thought of as representing some synchronous spontaneous firing of nerve fibers innervating the 12.5-25 position, and pathological condition, ASECA can present two main peaks, a relatively narrow one Ç200 Hz and a kHz tonotopic area (Cazals and Huang 1996) . Accordingly, in response to a tone a number of fibers will be driven by broader one Ç1 kHz. The 200-Hz peak was inconsistently found in control cats (Martin et al. 1993 ; Schreiner and the tone and will no longer participate to the synchronous spontaneous firing resulting in a decrease of the ASECASnyder. 1987) and not found in guinea pigs (Cazals and Huang 1996; Dolan et al. 1990 ). After one high dose of 1-kHz peak. It is known that pure tones at middle or high sound pressure levels will produce some lateral inhibition, salicylate in cats an emergence of the 200-Hz peak was seen J1007-7 / 9k2d$$oc45 09-30-98 08:49:32 neupa LP-Neurophys akin to the well-known two-tone suppression, which would in only two animal experiments (Boettcher et al. 1989; Jastreboff et al. 1988) ; plasma concentrations of salicylate were result in a decrease of the ASECA-1-kHz peak; this may be the main mechanism for tones at 8 and 4 kHz, which found of the same order as in humans (Day et al. 1989) .
A follow-up study indicated no accumulation in plasma or start inducing ASECA decrease at 30-50 dB SPL. It can be speculated that in salicylate-treated animals the ASECA-1-perilymph (Jastreboff et al. 1988) . Data from humans indicate that for repetitive daily doses the plasma salicylate conkHz increase reflects strongly increased synchronized activity that would be more resistant to disruption by pure tones centration does not show saturation over a wide range; interestingly the amount of hearing loss presents a rather linear at ¢16 kHz, whereas tones at 8 kHz and possibly at 4 kHz would still induce lateral inhibition and thus decrease the relation with plasma concentration; however tinnitus intensity appears to saturate at higher salicylate concentrations ASECA-1-kHz peak. This explanation does not involve the efferent cochlear innervation, which does not play a role in (Day et al. 1989) . Over the same time course of several hours after one salicylate injection animal experiments indilateral inhibition (Kiang 1968) , and is in line with the unaltered effect of a contralateral noise observed in salicylate-cate a concentration of salicylate in the stria vascularis (Ishii et al. 1967) , alterations of cochlear blood supply (Cazals et treated animals.
Lidocaine is the only drug with well-established sup-al. 1988; Didier et al. 1993) , and decrease of prostaglandins with increase of cochlear leukotrienes levels (Jung et al. pressive effects on tinnitus in humans (Murai et al. 1992) . It diminishes or suppresses tinnitus in a majority of patients, 1993). One physiological basis of acute salicylate ototoxicity is thus likely to originate from altered arachidonic acid but in Ç15% of cases it has no effect or it worsens tinnitus. In addition, the tinnitus-suppressing effects of lidocaine seem to metabolism, possibly mediating blood supply deficiencies (Jung et al. 1993) . No biochemical data are available condepend on the pathological state of the cochlea, patients with normal hearing being least responsive (Martin and Colman cerning repetitive salicylate treatment as in this study, but it can be speculated that habituation over days of treatment 1980; Melding et al. 1978) . In humans lidocaine was most effective when given intravenously; in our experiments on could occur in catecholaminergic control of blood supply.
An involvement of outer hair cell in salicylate ototoxicity awake animals intravenous injection is difficult. Thus an intramuscular route was adopted. This could explain why is indicated by studies on otoacoustic emissions in humans (Long and Tubis 1988; McFadden and Plattsmier 1984) , in we did not observe effects of lidocaine in our experiments. It could also be that the absence of lidocaine effect might in vitro experiments on outer hair cells (Dieler et al. 1991; Kakehata and Santos-Sacchi 1996; Tunstall et al. 1995) , be related to the absence of threshold elevation. In previous animal experiments the effect of lidocaine was tested only and in in vivo experiments (Murugasu and Russell 1995; Stypulkowski 1990) . Interestingly the comparative study of on acute salicylate-induced alterations, and few data are available. At the level of the auditory nerve, with a dose of salicylate-induced changes in basilar membrane mechanics, cochlear microphonics, and CAP in the guinea pig indicates lidocaine equivalent to that effective in humans, little effect was observed (Evans et al. 1981) ; with a dose four times that sensorineural alterations far outlast mechanical modifications (Murugasu and Russell 1995) . This may correspond larger a reduction of the spectral peak previously increased by salicylate was observed when lidocaine was given intra-to the dissociation of ASECA and CAP observed in this study. venously (Martin et al. 1993; Schreiner and Snyder 1987) but not when given intracochlearly (Lenarz et al. 1990) . At the inferior colliculus a clinical dose of lidocaine clearly (Manabe et al. 1997) . The effects of lidocaine Otologie, INSERM, Université de la Méditérannée Aix-Marseille II, Faculté on tinnitus may thus occur in the CNS and not in the cochlea, de Médecine Nord, Boulevard Pierre Dramard, 13916 Marseille Cedex 20, France. in agreement with its classification as a CNS depressant (see Murai et al. 1992) . The absence of effects at the cochlear Received 9 December 1997; accepted in final form 29 June 1998. level seen in this study is in line with this proposition. alterations Effects of sodium salicylate on evoked-response measures of hearing. Hear. Res. 42: 129-142, 1989. The kinetics of salicylate concentration in plasma and in BOETTCHER, F. A. AND SALVI, R. J. Salicylate ototoxicity: review and synthe cochlea during hours after a single injection of salicylate thesis. Am. J. Otolaryngol. 12: 33-47, 1991 . CAZALS, Y. AND HUANG, Z. W. Average spectrum of cochlear activity: a show a time course quite similar to that previously reported possible synchronized firing, its olivo-cochlear feedback and alterations in animal experiments for hearing loss and that observed for under anesthesia. Hear. Res. 101: 81-92, 1996. ASECA decrease. After a single injection, salicylate concen-CAZALS, Y., LI, X. Q., AUROUSSEAU, C., AND DIDIER, A. Acute effects of tration in the plasma and in the cochlea reaches a peak level noradrenalin related vasoactivity agents on the ototoxicity of aspirin: an after Ç1-3 h and decays slowly in the following hours (Ishii experimental study in the guinea pig. Hear. Res. 36: 89-96, 1988 . CHEN, G. AND JASTREBOFF, P. J. Salicylate-induced abnormal activity in Jastreboff and Sasaki 1991) . The reduction of the inferior colliculus of rats. Hear. Res. 82: 158-178, 1995. ASECA decrease observed over weeks of salicylate treat-CRIFO, S. Aspirin ototoxicity in the guinea pig. J. Otorhinolaryngol. 37: ment suggests that some kind of saturation was reached in 27-34, 1975. the cochlea after 2 and 3 wk of salicylate treatment. To our DAY, R. O., GRAHAM, G. G., BIERI, D., BROWN M., CAIRNS D., HARRIS G., HOUNSELL, J., PLATT-HEPWORTH, S., REEVE, R., SAMBROOK, P. M., AND knowledge repetitive daily salicylate injections were studied J1007-7 / 9k2d$$oc45 09-30-98 08:49:32 neupa LP-Neurophys
